Richard Ridinger

Richard Ridinger currently works at Recipharm AB, as Chairman from 2021, Brenntag SE, as Chairman-Supervisory Board from 2023, Firmenich SA, as Director, Firmenich International SA, as Independent Director, and DSM-Firmenich AG, as Independent Director from 2023.
Mr. Ridinger also formerly worked at Lonza Group AG, as Chief Executive Officer from 2012 to 2019, Lonza Biologics Plc, as Chief Executive Officer, Lonza Houston, Inc., as Chief Executive Officer, Firmenich SA, as Director, Henkel & Cie.
AG, as Director-Global Business from 1999 to 2000, Evolva Holding SA, as Non-Executive Director from 2020 to 2022, SHL Medical AG, as Director, Cognis BV, as Executive Vice President, Cognis Corp., as Executive Vice President, and Cognis GmbH, as Executive Vice President-Care Chemicals from 2006 to 2011.
Mr. Ridinger received his undergraduate degree in 1986 from the University of Karlsruhe.